Divi's Laboratories revenue and financials
₹9,595.50Change from previous close: +0.53%Absolute change: +₹50.50
In the fiscal year ended March 2026, Divi's Laboratories reported revenue of ₹104.76B (+12.34% year over year). Net income was ₹25.68B, a net margin of 24.5%.
Fiscal year ending in March. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +12.34%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +17.21%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 24.5%
- FY to Mar 2025: 23.5%
Financial data
Amounts in millions of INR; per-share values in INR; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 |
|---|---|---|---|---|---|
| Operating cash flow | 27,380 | 16,530 | 12,610 | 24,590 | — |
| Depreciation and amortization | 4,630 | 4,020 | 3,780 | 3,430 | — |
| Capital expenditure | -25,200 | -14,380 | -10,030 | -4,730 | — |
| Investing cash flow | -22,190 | -8,040 | -2,690 | -27,070 | — |
| Financing cash flow | -8,040 | -7,990 | -7,990 | -7,970 | — |
| Dividends paid | -7,970 | -7,960 | -7,960 | -7,960 | — |
| Net change in cash | -2,850 | 500 | 1,930 | -10,450 | — |
| Free cash flow | 2,180 | 2,150 | 2,580 | 19,860 | — |